Congressional Cannabis Caucus leader OK with hemp ban (Newsletter: June 9, 2025)
From toxifillers.com with love
Congresswoman talks medical marijuana for cancer; GOP rep “excited” to work on psychedelics w Trump admin; DEA psilocybin letter; NH marijuana bill
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
(function() {
window.mc4wp = window.mc4wp || {
listeners: [],
forms: {
on: function(evt, cb) {
window.mc4wp.listeners.push(
{
event : evt,
callback: cb
}
);
}
}
}
})();
Your support makes Marijuana Moment possible…
Hold on, just one second before you read today’s news. Have you thought about giving some financial support to Marijuana Moment? If so, today would be a great day to contribute. We’re planning our reporting for the coming months and it would really help to know what kind of support we can count on.
Check us out on Patreon and sign up to give $25/month today:
https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
Congressional Cannabis Caucus co-chair Rep. Dave Joyce (R-OH) and House Agriculture Committee Chairman Glen Thompson (R-PA) defended legislation to ban most consumable hemp products, saying that companies are exploiting current law to sell intoxicants.
Rep. Ashley Hinson (R-IA) spoke about how using medical cannabis helped her aunt treat cancer symptoms and “allowed her to be able to eat and stay alive long enough to fight as long as she did”—but added that she’s concerned about “free-for-alls around marijuana” with broader legalization.
Rep. Dan Crenshaw (R-TX) said he’s “excited” to work with the Trump administration to advance psychedelics reform, expressing enthusiasm about federal health officials who appear “friendlier” to the issue compared to those who served under past presidents.
Attorneys for a doctor seeking to reschedule psilocybin so he can administer it to terminally ill patients are demanding an update from the Drug Enforcement Administration on its prior commitment to submit a request for a scientific review of the psychedelic from the U.S. Department of Health and Human Services.
The New Hampshire Senate rejected a House bill to decriminalize psilocybin, but the House advanced a backup plan to more incrementally lower penalties for the psychedelic as well as separate legislation to legalize home cultivation of medical cannabis.
Missouri Division of Cannabis Regulation officials will begin conducting unannounced visits to marijuana dispensaries to collect products for verification testing on July 1.
Texas lawmakers this session passed legislation to expand medical marijuana access, ban hemp products and support psychedelics research—while harm reduction legislation to combat drug overdoses stalled.
Massachusetts marijuana business owners argue in a new op-ed that a pending bill to raise the license ownership cap and change other rules is a rare example of “a policy that actually reflects the realities of running a cannabis business in today’s market.”
Lovewell Farms’s Mike Simpson argues in a new op-ed that pending Rhode Island bills to restrict hemp-derived THC beverages “misrepresent both the science behind these products and the legal infrastructure already in place.”
/ FEDERAL
Former White House Chief Strategist Steve Bannon said that reported drug use by former Department of Government Efficiency head Elon Musk should be investigated amid his feud with President Donald Trump.
Rep. Jason Crow (D-CO) said psychedelic therapy is “very promising, but we need good data.”
Former Sen. Kyrsten Sinema (I-AZ) discussed her support for psychedelics reform.
/ STATES
Louisiana Gov. Jeff Landry (R) signed a kratom criminalization bill into law.
Nebraska Gov. Jim Pillen (R) reportedly caused a vacancy on the Liquor Control Commission because he wanted someone with more “cannabis experience” in the role.
A former Maine representative reportedly helped several Chinese nationals establish marijuana cultivation operations.
A Massachusetts judge denied the state treasurer’s effort to keep records related to her firing of the top marijuana regulator secret.
Rhode Island regulators designated disproportionately impacted areas for the purposes of marijuana social equity business applicant eligibility.
Washington State regulators are considering rules concerning acceptable forms of identification for age verification for purchase of marijuana and alcohol.
Ohio regulators published guidance on child-resistant packaging for marijuana products.
An Oregon regulator spokesperson said they are not aware of any legislature-directed funds to support the psilocybin services program for 2025-27, so officials “must evaluate the possibility of increasing licensing fees.”
The Pennsylvania Department of Drug and Alcohol Programs is accepting proposals on “cannabis/recreational marijuana” and other topics for an Emerging Drug Trends Symposium it is hosting in November.
Minnesota regulators sent a newsletter with updates on various cannabis compliance issues.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
/ LOCAL
Officials from several Ohio municipalities are pushing state lawmakers not to divert marijuana revenue away from localities.
/ INTERNATIONAL
A German court ruled that prisoners are allowed to possess up to 50 grams of cannabis in their cells while serving their sentences.
/ SCIENCE & HEALTH
A study concluded that the “multifaceted effects of CBD, ranging from molecular-level modulation to behavioral improvements, underscore its potential as a comprehensive therapeutic approach for” Alzheimer’s disease.
A study of rats found that “full-spectrum Cannabis sativa extract enhances gut-peripheral organ integrity after experimental ischemic stroke.”
/ ADVOCACY, OPINION & ANALYSIS
A former Arkansas Democratic Party chair is taking on an ownership stake in a medical cannabis dispensary.
The Fort Worth Star-Telegram editorial board criticized the Texas lieutenant governor’s push to criminalize consumable hemp products with any amount of THC.
/ BUSINESS
Vireo Growth Inc. closed its acquisition of Proper Brands through the acquisition of NGH Investments, Inc. and Proper Holdings Management, Inc.
AYR Wellness Inc. received a failure to file cease trade order from Canadian officials.
Mindbloom, Inc. is suing Dow Jones & Company, Inc. over a Wall Street Journal article about actor Matthew Perry’s death after taking ketamine that allegedly libeled the company.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
(function() {
window.mc4wp = window.mc4wp || {
listeners: [],
forms: {
on: function(evt, cb) {
window.mc4wp.listeners.push(
{
event : evt,
callback: cb
}
);
}
}
}
})();
Photo courtesy of Chris Wallis // Side Pocket Images.
The post Congressional Cannabis Caucus leader OK with hemp ban (Newsletter: June 9, 2025) appeared first on Marijuana Moment.